Clinical Pathways

Latest News
May 22nd 2024

ASCO Certifies OneOncology’s Treatment Pathways

February 14th 2024

Edward R. Arrowsmith, MD, MPH: Trust and Compromise Are Essential in Building Oncology Clinical Care Pathways

August 17th 2023

CIinical Pathways: August 2023

February 23rd 2023

With Broad Input, Clinical Pathways Making a Difference for End Users

February 23rd 2023

OneOncology’s Clinical Pathways Covers Best Practices for 90% of Patients, Says Ted Arrowsmith, MD, MPH

Video Interviews
View All
August 18th 2022

Evaluating and Integrating New Data Into NSCLC Clinical Pathways

August 18th 2022

Immune Checkpoint Inhibitors in NSCLC Therapy

August 8th 2022

NSCLC Outcomes: Clinical and Non-Clinical Evidence

August 8th 2022

Using Clinical Pathways to Treat NSCLC

June 20th 2020

Dr Blythe Adamson: Electronic Health Records Can Serve as an Invaluable Learning Tool

May 11th 2020

Dr Ray Page Outlines Benefits, Challenges of Using Clinical Pathways

December 16th 2018

Dr Robert Daly Explains the Importance of Updating Pathways With New Data

December 8th 2018

Dr Lawrence Shulman Discusses Pathways and Improvements in Breast Cancer Treatment

November 21st 2018

Lyn Fitzgerald Discusses How NCCN Defines and Assesses Value in Cancer Care

September 19th 2018

Dr Denalee O'Malley Highlights Gaps in Cancer Treatment Communication

Podcasts
View All
April 15th 2017

Podcast: This Week in Managed Care - Guidelines Controversy, and Other News

More News

David Jackman, MD
February 23rd 2023

David Jackman, MD, on Clinical Pathway Buy-in, Process for Updates

Hayden E. Klein
Jeff Patton, MD
February 23rd 2023

Jeffrey Patton, MD, on Setting Standards of Care Through OneOncology’s Clinical Pathways Program

Hayden E. Klein Laura Joszt, MA
AJMC EBO logo
February 21st 2023

Guideline Adherence “Can Make a Real Difference in Someone’s Life,” Schatz Says

Hayden E. Klein
To Support Pathways, OneOncology Creates Disease Groups
July 19th 2022

To Support Pathways, OneOncology Creates Disease Groups

AJMC Staff
Each disease group guides and approves OneOncology clinical pathways to reflect evidenced-based national guidelines, which are updated often as new trial results are published or presented at major scientific meetings.
Real-World Evidence Is Key to Accelerating Oncology Approvals
June 21st 2021

Real-World Evidence Is Key to Accelerating Oncology Approvals

Jennifer B. Christian, PharmD, MPH, PhD
PATHWAYS: Oncology Care Pathways Launched by Payers: What Are the Trends?
June 20th 2021

PATHWAYS: Oncology Care Pathways Launched by Payers: What Are the Trends?

Allison Inserro
NCCN, Pfizer Grants Section to Collaborate on Biosimilars Initiative
July 2nd 2020

NCCN, Pfizer Grants Section to Collaborate on Biosimilars Initiative

AJMC Staff
Applicants should show how they would measure biosimilars use and safety in both academic and community practice settings.
Clinical Pathways Helped Health System Lower Costs, Boost Trial Enrollment Across Multiple Sites
June 25th 2020

Clinical Pathways Helped Health System Lower Costs, Boost Trial Enrollment Across Multiple Sites

Mary Caffrey
The savings occurred even while more patients in the health system were enrolling in clinical trials, according to an abstract presented during the American Society of Clinical Oncology 2020 Virtual meeting.
CMS Issues Rules to Promote Value-Based Contracting, Pay for High-Cost Therapies in Medicaid
June 18th 2020

CMS Issues Rules to Promote Value-Based Contracting, Pay for High-Cost Therapies in Medicaid

Mary Caffrey
Administrator Seema Verma said the proposal would create opportunities "for drug manufacturers to have skin in the game through payment arrangements that challenge them to put their money where their mouth is."
Study Finds Almost All Deviations From Clinical Pathways Were Justified
June 13th 2020

Study Finds Almost All Deviations From Clinical Pathways Were Justified

Mary Caffrey
Researchers warned that financial incentives that focus on a percentage of pathway compliance could “paradoxically harm the quality of care."
How Does Cardiotoxicity Present Itself in Patients With Cancer?
June 12th 2020

How Does Cardiotoxicity Present Itself in Patients With Cancer?

Maggie L. Shaw
Three abstracts presented at this year’s annual meeting of the American Society of Clinical Oncology focused on cardiotoxic effects of cancer treatment and how cardiac disease remains a barrier to effective cancer therapy among patients with cancer and survivors.
Site Logo
June 5th 2020

How Technology Can Help Health Facilities Reopening for Elective Procedures

Maura Cash, RN, BSN, CASC
Site Logo
June 3rd 2020

OCM, Other APM Timelines Extended Due to COVID-19

Mary Caffrey
CMS Administrator Seema Verma announced the update today in a blog post in Health Affairs.
Clinical Decision Tools Within EHR That "Nudge" vs "Force" Boost Pathway Compliance, Study Finds
May 30th 2020

Clinical Decision Tools Within EHR That "Nudge" vs "Force" Boost Pathway Compliance, Study Finds

Mary Caffrey
Debra A. Patt, MD, MPH, MBA, a breast cancer specialist at Texas Oncology is the lead author on the study being presented at ASCO.
NCCN Releases Patient Guidelines for Head, Neck Cancer
May 28th 2020

NCCN Releases Patient Guidelines for Head, Neck Cancer

Allison Inserro
To help patients and their caregivers cope, the National Comprehensive Cancer Network (NCCN) this week completed a 3-book series that explains care and management options for those with head and neck cancer.
Care Not in Line With Guidelines for HER2-Negative MBC Has Worse Outcomes in Elderly Women
May 23rd 2020

Care Not in Line With Guidelines for HER2-Negative MBC Has Worse Outcomes in Elderly Women

AJMC Staff
More than one-quarter of elderly women with HER2-negative metastatic breast cancer did not receive care in accordance with National Comprehensive Cancer Network (NCCN) treatment guidelines, and that was linked to higher mortality as well as higher Medicare costs.
ASTRO: Amid COVID-19, PPE Shortages, Fewer Visits, and New Ways to Fight Cancer
May 23rd 2020

ASTRO: Amid COVID-19, PPE Shortages, Fewer Visits, and New Ways to Fight Cancer

Mary Caffrey
Findings from the American Society for Radiation Oncology (ASTRO) highlight the growing financial strain at freestanding clinics, including those that say they will lose half their annual revenue.
Collaboration Leads to Clinical Pathways Success for One Illinois Practice
May 22nd 2020

Collaboration Leads to Clinical Pathways Success for One Illinois Practice

Maggie L. Shaw
Cancer Care Specialists of Illinois was able to reduce its median total drug spend by a notable 13.5%—$250,000 per medical oncologist—versus other practices enrolled in the Oncology Care Model, between the first quarters of 2017 and 2019, through the use of evidence-based clinical pathways.
PAPER OF THE WEEK: Predictions About Clinical Pathways
February 22nd 2020

PAPER OF THE WEEK: Predictions About Clinical Pathways

Mary Caffrey
With our current issue of Evidence-Based Oncology™ focusing on clinical pathways in cancer care, we look back at one of our most-read papers of 2016.
Site Logo
February 20th 2020

Impact of Next-Generation Sequencing Tests on Clinical Pathways for Cancer Care

Lance Baldo, MD
With patients living longer thanks to new therapies, we need more accurate, sensitive, and standardized tools to guide their therapy.
Site Logo
February 19th 2020

Clinical Pathways: A Critical Component of Success in Episodes of Care

Lili Brillstein, MPH Brian Currie
Site Logo
February 19th 2020

Clinical Pathways: Reducing Costs and Improving Quality Across a Network

Marcus Neubauer, MD
As the cost of oncology drugs only continues to rise, incorporating clinical pathways into cancer care helps streamline the integration of evidence-based best practices while improving quality and reducing costs for patients and payers.
Site Logo
February 19th 2020

Lessons From the Front: Designing and Implementing Clinical Pathways by and for Clinicians

David M. Jackman, MD Joanna Hamilton, MA, MS Emily Foster, MPH Craig A. Bunnell, MD, MPH, MBA Louis Culot, MA Carole Tremonti, RN, MBA Joseph O. Jacobson, MD, MSc
As cancer care becomes more complex and more expensive, decision-support algorithms offer a mechanism to define best practice, reduce unwarranted variation, and control costs across growing networks.
Site Logo
June 17th 2019

US Care Pathways: Continued Focus on Oncology and Outstanding Challenges

Anita Chawla, PhD Kimberly Westrich, MA Angela Dai, BS, BA Sarah Mantels, MA Robert W. Dubois, MD, PhD
The authors examined the latest trends in development, implementation, and evaluation of care pathways and the impact of the movement toward value-based care.
NCCN Releases Clinical Practice Guidelines for Pediatric ALL
May 30th 2019

NCCN Releases Clinical Practice Guidelines for Pediatric ALL

Allison Inserro
The National Comprehensive Cancer Network (NCCN) Thursday released its first set of clinical practice guidelines for pediatric cancer, saying the new acute lymphoblastic leukemia (ALL) guidelines are the first of several planned to address various pediatric cancers.
Site Logo
February 26th 2019

Reporting and Design

Mary Caffrey Jaime Rosenberg
Updates on reporting otucomes and pathway design from Patient-Centered Oncology Care®.
Site Logo
December 27th 2018

Roadmap to Success in the Oncology Care Model: Tapping Into Human Potential via Sustained Engagement

Kashyap Patel, MD
The authors, led by Kashyap Patel, MD, offer the first in a series of articles on how Carolina Blood and Cancer Care Associates leveraged the strength of its team to take part in the Oncology Care Model.
The Goldilocks Principle: A Personalized Breast Cancer Treatment That Is "Just Right" for You
December 24th 2018

The Goldilocks Principle: A Personalized Breast Cancer Treatment That Is "Just Right" for You

Molly MacDonald
Molly MacDonald, the founder and CEO of The Pink Fund, writes about how patients with breast cancer can approach decisions about choosing among disparate treatment protocols.
Analysis Shows Benefit of Abemaciclib in Women With Worse Prognosis
December 19th 2018

Analysis Shows Benefit of Abemaciclib in Women With Worse Prognosis

Allison Inserro
A recent study of abemaciclib, a cyclindependent kinase 4 and 6 inhibitor for metastatic breast cancer, found that it helped all women with hormone receptor–positive, human epidermal growth factor receptor 2–negative disease, and that it was particularly beneficial in women with a worse prognosis.
BCI Index Helps Clinicians Individualize Patient Treatment
December 14th 2018

BCI Index Helps Clinicians Individualize Patient Treatment

Samantha DiGrande
During the San Antonio Breast Cancer Symposium held in San Antonio, Texas from December 4-8, 2018, Biotheranostics presented new data evaluating the impact of the Breast Cancer Index (BCI) in patients with early stage hormone receptor positive (HR+) breast cancer who are classified as an immediate risk for distant recurrence by previous genomic testing.
12345678
...
14>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo